Holen Sie sich die Stockscreener-App
2.49
2.05%
0.05
Handel nachbörslich:
2.46
-0.03
-1.20%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMRA?
Forum
Prognose
Aktiensplit
Biomerica Inc Aktie (BMRA) Neueste Nachrichten
Biomerica Inc. (BMRA) Q1 2026 Earnings: Negative EPS Persists Amid Pre-Revenue StagePeak Earnings Alert - Newser
BMRA Q1 2026 Earnings: Biomerica Reports Net Loss of $0.44 Per Share Amid Ongoing Development Efforts - Newser
Biomerica (BMRA) Q1 2026 Earnings: Revenue $N/A, Matching ViewsExpert Entry Points - Newser
ConsumerDirect names Gary Lu as chief financial officer - Investing.com UK
ConsumerDirect names Gary Lu as chief financial officer By Investing.com - Investing.com South Africa
ConsumerDirect adds new CFO to scale its subscription business - Stock Titan
Biomerica (BMRA) Stock Analysis: Falls -3.85%, Watching $2.14 2026-05-18Most Watched Stocks - newser.com
Should You Sell Biomerica (BMRA) After -2.90% Drop? 2026-05-17Crowd Sentiment Stocks - Newser
TradingKey - TradingKey
What Biomerica (BMRA) subscription metrics reveal about retention | BMRA Q1 2026: Biomerica Posts Wider Loss Amid Cost PressureCrowd Breakout Signals - Newser
BMRA | BIOMERICA INC Insider Trading - Quiver Quantitative
What nobody tells you about Biomerica (BMRA) stock (Smart Money Outflows) 2026-05-08Golden Cross - Newser
Why are smart money investors paying attention to Biomerica (BMRA)? (On the Radar) 2026-05-07Verified Stock Signals - newser.com
How Biomerica (BMRA) competitive position is evolving (Bullish Momentum) 2026-05-06Social Investment Platform - newser.com
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 - Weekly Voice
An IBS diet-guided therapy gets a slot at the world's biggest GI meeting - Stock Titan
BMRA (Biomerica) falls 0.47% after reporting Q1 2026 negative EPS of $-0.44 with no available analyst consensus estimates.Social Buy Zones - newser.com
BMRA (Biomerica Inc.) posts 1.9 percent year-over-year Q1 2026 revenue dip, shares gain 4.27 percent. - Cổng thông tin điện tử tỉnh Lào Cai
BMRA (Biomerica Inc.) slips 0.91% following Q1 2026 earnings release with no available analyst consensus estimates.Hedge Fund Inspired Picks - Xã Thanh Hà
Biomerica Q3 Sales Fall, Net Loss Widens Amid Restructuring - Orange County Business Journal
BMRA Biomerica reports 1.9% year-over-year Q1 2026 revenue decline, shares drop 2.52% in today’s session.Popular Market Picks - Newser
Biomerica (BMRA) Stock Bid Wall (Near Lows) 2026-04-18Live Trade Sharing - Newser
BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill
Biomerica (BMRA) Secures Medicare Coverage for inFoods IBS Tests - GuruFocus
Biomerica, Inc. Receives Medicare Confirmation for inFoods® IBS Claims Processing Pathway - Quiver Quantitative
Biomerica Inc Announces Medicare Administrative Contractor Confirmation of Individual Claim Review For Infoods Ibs Test - marketscreener.com
Biomerica (BMRA) Stock Bonus Issue (Investor Interest) 2026-04-15Trader Community Insights - Cổng thông tin điện tử Tỉnh Sơn La
Biomerica, Inc., Phoenix Airmid Biomedical And CanAlt Health Labs Launch inFoods IBS Platform In Canada - marketscreener.com
Biomerica reports net loss of USD 1.31M in Q3 2026 - Medical Buyer
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - The Manila Times
Up to 5 million Canadians have IBS; Biomerica brings inFoods north - Stock Titan
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales - TradingView
Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Weekly Voice
Biomerica Reports Third Quarter Fiscal 2026 Financial Results, Highlights Real-World Efficacy of inFoods® IBS and Growth in European Revenue - Quiver Quantitative
BRIEF-Biomerica Q3 Net Income USD -1.31 Million - TradingView
Press Release: Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Moomoo
Biomerica 10-Q: Revenue $0.99M, EPS $(0.44) for Q3 ended Feb 28, 2026 - TradingView
Biomerica (BMRA) revenue falls 22% as losses persist and going concern risk disclosed - Stock Titan
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 - marketscreener.com
Update Report: Will Biomerica Inc stock benefit from M A2026 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
What metrics matter for Biomerica (BMRA) Stock valuation | Price at $2.05, Down 4.11%Expert Insights - Newser
Aug Breakouts: Is Biomerica Inc a strong candidate for buy and holdMarket Volume Summary & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Press Releases about Biomerica, Inc.Common Stock (Nasdaq:BMRA) - FinancialContent
How does Biomerica (BMRA) Stock compare to competitors | Price at $2.16, Up 0.47%Take Profit Levels - Newser
Biomerica (BMRA) to Post Earnings on Monday - Defense World
BMRA: BiomericaInteractive Chart - Zacks Investment Research
Is Biomerica (BMRA) Stock Moving Sideways | Price at $2.17, Down 0.91%Institutional Buying - Newser
Should value investors consider Biomerica Inc2026 Price Targets & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
AI Stocks: Whats the fair value of Biomerica Inc stockMarket Risk Report & Fast Gain Swing Alerts - baoquankhu1.vn
Rate Hike: What is the PEG ratio of Biomerica Inc2026 EndofYear Setup & Stock Portfolio Risk Management - baoquankhu1.vn
BMRA PE Ratio & Valuation, Is BMRA Overvalued - intellectia.ai
Biomerica gets first commercial order for H pylori test - MSN
Biomerica Receives First Commercial Order for its H. pylori test from one of the Largest Clinical Laboratory Chains in Europe - marketscreener.com
Biomerica (BMRA) Secures First European Order for H. pylori Test - GuruFocus
First European commercial order landed: US diagnostic product company Biomerica announces that its Helicobacter pylori detection product HP Detect™ has received the first commercial order from one of Europe's largest clinical laboratory chains. - Bitget
Biomerica Secures First Commercial Order for Hp Detect™ from Major European Laboratory Chain - Quiver Quantitative
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect) from One of the Largest Clinical Laboratory Chains in Europe - Bitget
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe - marketscreener.com
Stomach cancer bacteria drives major lab’s first order of Hp Detect test - Stock Titan
Biomerica dank Laborauftrag für Test im Aufwind - TradingView
0.22%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):